Drug metabolism in human recombinant CYP2E1 assessed as (Z)-N'-hydroxy-6-(5-(5-((Z)-N'-methoxycarbamimidoyl)pyridin-2-yl)furan-2-yl nicotinimidamide f...

Basic Information

ID: ALA3536078

Type: ADME

Description: Drug metabolism in human recombinant CYP2E1 assessed as (Z)-N'-hydroxy-6-(5-(5-((Z)-N'-methoxycarbamimidoyl)pyridin-2-yl)furan-2-yl nicotinimidamide formation treated with DB868

Format: BAO_0000357

Organism: Homo sapiens

Target: Cytochrome P450 2E1(ALA5281)

Document: ALA3525966

Drug metabolism in human recombinant CYP2E1 assessed as (Z)-N'-hydroxy-6-(5-(5-((Z)-N'-methoxycarbamimidoyl)pyridin-2-yl)furan-2-yl nicotinimidamide formation treated with DB868: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA3536078

Drug metabolism

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
402.84	1.94	1.94

Parent Molecular Weight

ALogP

Polar Surface Area

402.84

1.94

Drug metabolism in human recombinant CYP2E1 assessed as (Z)-N'-hydroxy-6-(5-(5-((Z)-N'-methoxycarbamimidoyl)pyridin-2-yl)furan-2-yl nicotinimidamide f...

Basic Information

Activity Charts

Compound Summary